Your browser doesn't support javascript.
loading
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
Elkrief, A; Derosa, L; Kroemer, G; Zitvogel, L; Routy, B.
Affiliation
  • Elkrief A; Department of Oncology, Segal Cancer Center, Jewish General Hospital, Montréal, Canada; Department of Oncology, Cedar's Cancer Center, McGill University Healthcare Center, Montréal, Canada.
  • Derosa L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France; National Institute for Health and Research (INSERM), Villejuif, France; Paris-Sarclay University, Gustave Roussy, Villejuif, France.
  • Kroemer G; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France; Metabolomics and Cell Biology Platforms, Villejuif, France; Paris Descartes University, Paris, France; Cordeliers Research Centre, National League Against Cancer, Paris, France; National Institute of Health and R
  • Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France; National Institute for Health and Research (INSERM), Villejuif, France; Paris-Sarclay University, Gustave Roussy, Villejuif, France.
  • Routy B; Research Centre for the University of Montréal (CRCHUM), Montréal, Canada; Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, Canada. Electronic address: bertrand.routy@umontreal.ca.
Ann Oncol ; 30(10): 1572-1579, 2019 10 01.
Article in En | MEDLINE | ID: mdl-31268133

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dysbiosis / Gastrointestinal Microbiome / Antineoplastic Agents, Immunological / Immunotherapy / Anti-Bacterial Agents / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dysbiosis / Gastrointestinal Microbiome / Antineoplastic Agents, Immunological / Immunotherapy / Anti-Bacterial Agents / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Country of publication: